IBB

Genentech Holds Out for Better Offer, Which Could Deliver a Boost to Biotech ETFs
August 14, 2008 – Biotechnology stocks and exchange traded funds (ETFs) could get a shot in the arm, as Genentech (DNA) rejected a takeover bid from Roche, which they feel has undervalued the company. Roche, the Swiss pharmaceutical company, offered... Continue Reading »

Five ETFs That Have Beared The Current Market
August 5, 2008 – Anyone who follows the markets knows that while some exchange traded funds (ETFs) might be down, other areas and ETFs are heading in the other direction. In our current bear market, there have bee several ETFs... Continue Reading »

Biotech ETFs Are a Matter of Personal Choice
July 27, 2008 – Biotechnology appeals to many investors, and with four different exchange traded funds (ETFs) focused on the class, is there a fund that is better than the rest? The sector is one of the few non-commodity related... Continue Reading »

Biotechnology ETFs Growing…Like Genetically Modified Crops?
July 16, 2008 – Biotechnology is the non-commodity exchange traded fund (ETF) area du jour, it seems. In a time where the markets seem bleak, the sector is delivering a ray of light. Genentech (DNA) this week upped its 2008... Continue Reading »

Can Biotech And Agriculture ETFs Get Acreage With Your Money?
July 10, 2008 – Not many exchange traded funds (ETFs) outside those focused on commodities are perched above their 200-day moving averages. That makes it worth noting that two biotechnology ETFs crossed the mark recently. Both iShares Nasdaq Biotechnology (IBB)... Continue Reading »

    • Tom Lydon: Thanks, Donato. We reread what we wrote, and realize that it was misleading and didn’t represent...
    • Tom Lydon: Hi Harry, The fund has not launched yet. We’ll let you know when it does. RVEI is the ticker symbol...
    • HARRY FOREMAN: I’M CONFUSED: WHAT IS THE SYMBOL? RICI RJI RVEI HAS NOT THE NEW FUND(RVEI) BEEN STARTED YET?
    • Tom Lydon: Hi Ted and Sheia, There is the PowerShares Financial Preferred (PGF), iShares S&P U.S. Preferred...
    • Tom Lydon: Thank you Paul for pointing this out. I apologize, it should be that ITA is down 15.5% year-to-date, not...

Recent Podcast

Tom Lydon Talks ETFs on FT Press

 
 Tom Lydon on FT Press - August 11, 2008: Play Now | Play in Popup | Download